Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Celgene Corporation is an American pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS) since…
History, Companies, Products & Art
Explore the main themes, entities and connections around Celgene. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
company million revlimid billion acquired drug treatment acquire new thalomid corporation lenalidomide ceo products would 2017 dr immunology 2019 jersey
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Celgene | Founded | 1986; 40 years ago (1986) | 1.00 | infobox |
| Celgene | Founder | Sol J. Barer | 1.00 | infobox |
| Celgene | Headquarters | Summit, New Jersey, U.S. | 1.00 | infobox |
| Celgene | Industry | Biotechnology | 1.00 | infobox |
| Celgene | Key people | Robert J. Hugin (executive chairman) Mark Alles (CEO) | 1.00 | infobox |
| Celgene | Net income | $4.046 billion (2018) | 1.00 | infobox |
| Celgene | Number of employees | 8,852 (2018) | 1.00 | infobox |
| Celgene | Parent | Bristol Myers Squibb | 1.00 | infobox |
| Celgene | Products | Revlimid Abraxane Pomalyst/Imnovid Thalomid Idhifa | 1.00 | infobox |
| Celgene | Revenue | $15.281 billion (2018) | 1.00 | infobox |
| Celgene | Total assets | $35.480 billion (2018) | 1.00 | infobox |
| Celgene | Total equity | $6.161 billion (2018) | 1.00 | infobox |
| Celgene | Traded as | Nasdaq: CELG | 1.00 | infobox |
| Celgene | Type | Subsidiary | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.